Hybrid Imaging Market Size Worth $9.8 Billion By 2026

The global hybrid imaging market size is expected to reach USD 9.8 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.5% CAGR over the forecast period. Increasing demand for accurate diagnostic techniques for cancer and cardiac disorders is expected to drive the market. Rising government initiatives for creating awareness regarding multimodal imaging devices are also expected to contribute toward market growth.

Increasing installation of such devices in research centers and institutions to enhance diagnostics in the field of oncology, cardiology, neurology, and others is expected to boost market growth. Leading players in the market are showcasing various multimodal imaging devices at medical conferences to increase their product reach. However, high cost and complications associated with these devices is expected to impede market growth during the forecast period.

Hybrid imaging devices require skilled professionals to understand the data collected by these combined devices. Therefore, various training programmes are conducted by several non-profit and government funded organizations to increase the adoption of hybrid imaging devices for the diagnosis of a disease.

North America dominated the hybrid/multimodal imaging market in 2018 and is expected to grow at a significant rate during the forecast period. The growth observed in this region is largely due to presence of global players and increasing adoption of advanced equipment such as hybrid imaging devices. Moreover, increasing awareness regarding nuclear medicine and molecular diagnostics in the region is expected to contribute toward the growth in this region.

Asia Pacific is expected register the strongest growth over the forecast period. This can be primarily attributed to growing usage of advanced devices such as PET/CT systems in radiology departments across emerging economies. Thriving medical tourism in numerous countries has piqued the interest of global market players, who are looking to invest in the development and launch of advanced software in the region. The Europe market is fueled by ongoing efforts by various non-profit organizations in conducting educational and training programs for scientists, physicians, technologists, physicists, radiographers, and others in the field.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/hybrid-imaging-market

Further key findings from the report suggest:

PET/CT systems held the largest share in 2018 based on type, and the segment is expected to grow at a significant pace due to increasing development and installation of these devices in various end users such as hospitals and diagnostic centers
SPET/CT systems segment in hybrid imaging market will exhibit the fastest growth rate during the forecast period. Data captured by SPET/CT helps in understanding the detailed morphology and pathogenesis of a disease, thereby enhancing the quality of diagnostic output
In 2018, the oncology segment held the dominant share of hybrid imaging systems market by application, largely due to increasing number of cancer cases and growing awareness for cancer diagnosis
The cardiology segment is expected to grow at the fastest pace during the forecast period. Cardiac hybrid imaging helps in accurately capturing morphological and functional information in a single setting, thereby easing the diagnosis of cardiac disorders
Hospitals held the largest market share in 2018 on the basis of end use, mainly due to higher installation of technologically advanced devices for early diagnosis and treatment of a disease
Geographically, Asia Pacific is expected to register the fastest growth rate during the forecast period due to increasing number of radiology departments in the region and launch of advanced software by leading players.

North America Extremity Tissue Expanders Market Worth $79.2 Million By 2025

The North America extremity tissue expanders market size is expected to reach USD 79.2 million by 2025, according to a new report by Grand View Research, Inc., exhibiting a 3.4% CAGR during the forecast period. Increase in number of road accidents and burn-related cases is driving the market. Rising incidence of congenital deformity is also anticipated to boost market demand.

As stated by the Centers for Disease Control and Prevention (CDC) in 2014, annually, around 40 million people in U.S. visit the emergency room because of trauma injuries including burns and severe fractures. Thus, demand for extremity tissue expanders for treatment of patients with severe hand and/or leg injuries resulting from road accidents or trauma is expected to increase in future.

Use of extremity tissue expanders is gaining popularity and has become the preferred treatment option for many congenital defects in adults as well as children. In addition, technological advancements in this field are expected to drive the market. For instance, advanced soft tissue expanders facilitate early closure of surgical or traumatic wounds without the need for further complicated plastic surgery.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/north-america-extremity-tissue-expanders-market

Further key findings from the study suggest:

Round shaped expanders held the largest share in 2017 owing to the various benefits associated with this shape as well as its wide availability with major companies
Anatomical shaped expanders contributed to a limited revenue share in 2017 owing to fewer products available with key manufacturers
Hospitals accounted for the largest market share in 2017 because they are considered to be the primary point-of-care for preliminary treatment
Burn centers are projected to show significant growth over the forecast period due to surge in burn-related injuries
U.S. held the dominant share in 2017 due to increase in number of reconstruction procedures, which are undertaken to improve patients’ physical appearance and self-confidence
Canada is anticipated to witness the highest growth over the forecast period owing to presence of a strong distribution network of a large number of medical devices manufacturers and a developed economy
Some of the major companies of the market are Mentor Worldwide LLC; Sientra, Inc.; PMT Corporation; Allergan; and KOKEN CO., LTD.

Medical Devices Reimbursement Market Worth $1169.8 Billion By 2027

The global medical devices reimbursement market size is expected to reach USD 1169.8 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The rising number of regulatory reforms and increasing efforts of healthcare providers to reduce costs and improve the quality of medical equipment are anticipated to propel the market growth. Medical device reimbursement is defined as the payment, a third-party private or public insurer pays to a healthcare provider for the cost incurred while using healthcare equipment.

The major factors fueling market growth are growing dependence on remuneration, increasing prevalence of chronic diseases, and growing preventive care. Rising focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more remuneration share from them. For instance, a fundamental paradigm shift towards incentivizing early diagnosis through remuneration is noticed across developed economies, such as screening for breast cancer.

With the increasing demand for healthcare equipment, the remuneration services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, an increasing number of people pursuing insurance and consolidation of the healthcare system are the major factors fueling the market.

North America held the highest revenue share of about 50.0% in the market in 2019 and is expected to maintain its dominance over the forecast period. Increasing adoption of healthcare devices reimbursement and raising awareness with regards to cost implications are expected to drive the market in the region. In addition, rising demand for healthcare equipment and an increasing number of healthcare centers is expected to drive the market in this region. With increasing chronic diseases, the demand for healthcare equipment is also increasing. As per the National Health Council Report, around 157.0 million people will suffer from multiple chronic conditions until 2020. Due to these reasons, the market is expected to show significant growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-devices-reimbursement-market

Further Key Findings From the Study Suggest:

The private player segment dominated the market with a share of 64.7% in 2019 due to the presence of a large number of private players
The hospitals segment dominated the market with a share of 49.6% over the forecast period due to recent technological developments and high patient footfall requiring the use of healthcare equipment
North America is expected to dominate the market over the forecast period owing to strong reimbursement framework
The market in Asia Pacific is projected to witness rapid growth during the forecast period owing to rising penetration of insurance services in rural and urban areas.

Cell Harvesting System Market Size Worth $10.17 Billion By 2025

The global cell harvesting system market is expected to reach USD 10.17 billion by 2025, according to a new report by Grand View Research, Inc. The increasing demand for stem cell-based therapies, owing to the growing base of aging population and increasing prevalence of chronic diseases, is one of the major factors contributing toward lucrative market growth.

Growing investment in stem cell research is one of the high impact rendering drivers contributing to the demand for stem cells, which thereby contributes to the growth of the cell harvesting system market. There has been a significant rise in the stem cell transplantation rate globally, which is another major driver for increasing demand across the globe. Growth in autologous stem cell transplantation along with increasing stem cell banking is stimulating demand for cell harvesting system.

The potential use of stem cells in regenerative medicine, such as in the case of cancer, trauma, congenital diseases, etc., is also one of the factors contributing to the demand for stem cells for research, thereby contributing toward the growth of cell harvesting system market across the globe. The rising prevalence of certain diseases such as cancer is expected to drive the growth of this market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cell-harvesting-systems-market

Further key findings from the report suggest:

Umbilical cord, bone marrow, peripheral blood, adipose tissue, and other sources are the application segments analyzed in this study. Peripheral blood dominates the application market and is expected to do maintain its dominance over the forecast period.
Hospitals held the largest share in the end-use segment and is expected to hold the largest share over the forecast period, as a majority of stem cell harvesting for transplantation and banking is done in hospitals. Rise in stem cell research is expected to contribute to the growth of stem cell harvesting in academic institutes and R&D centers.
North America and Europe dominated the cell harvesting system market owing to the high rate of stem cell transplantation and research. Aging population and rising prevalence of cancer are further expected to contribute to the growth of the market in these regions.
Some of the key players are Argos Technologies, Inc.; Perkin Elmer, Inc.; Brand GmBh + CO KG; Arthrex, Inc.; Avita Medical; Tomtec; Terumo Corporation; Teleflex, Inc.; and Bertin Technologies.

Veterinary X-ray Market Worth $651.76 Million By 2026

The global veterinary X-ray market size is expected to reach USD 651.76 million by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.6% during the forecast period. Rising pet adoption is fueling the need for healthcare facilities, and growing penetration of direct (capture) radiography as well as technological advancements in X-ray systems are some key factors driving growth. As per IDEXX Laboratories, there has been an incremental growth of 2.2% in clinical visits per practice for U.S. companion animals in the first quarter of 2019. The aforementioned factors highlight the untapped opportunities for animal diagnostics segment, inclusive of imaging.

X-ray devices help veterinarians and laboratory technicians to diagnose many conditions, including bladder stones & tumors and determine foreign bodies in an animal’s stomach. These devices also assist in locating fractures and internal injuries. Increasing awareness about animal health along with high adoption of advanced technologies is expected to contribute toward market growth over the forecast period. For instance, advancements in digital radiography and rise in awareness about their benefits such as cost-effectiveness and higher efficiency.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/veterinary-x-ray-market

Further key findings from the study suggest:

Computed radiography held a dominant share in 2018 due to increasing adoption in animal health practices
Digital X-ray equipment segment is expected to gain popularity in the coming years owing to user-friendliness and enhanced productivity
The portable segment is anticipated to witness lucrative CAGR over the forecast period due to increase in awareness about its benefits
Small companion animals segment dominated the veterinary X-ray market as of 2018 due to increasing pet adoption along with rising awareness & concern among pet owners
The hospitals and clinics segment held a dominant revenue share owing to rise in patient footfall
North America accounted for a dominant revenue share as of 2018 due to rise in the number of pets and increase in willingness to pay for their healthcare
SOUND; IDEXX Laboratories, Inc.; FUJIFILM Holdings America Corporation, Heska Corporation, and Canon Inc. are some of the major players with broad product portfolios and significant regional presence
Companies are adopting various strategies such as product development, mergers & acquisitions, partnerships, collaborations, and regional expansion to gain a competitive edge in the market.

Wound Care Market Size Worth $25.1 Billion By 2026

The global wound care market size is expected to reach USD 25.1 billion by 2026, according to a new report by Grand View Research, Inc., registering a 3.9% CAGR during the forecast period. Increase in prevalence of chronic diseases globally, rising number of ambulatory surgical centers (ASCs), and growing geriatric population are key factors driving the global market.

ASCs offer a variety of services such as surgical assistance, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, and gastro intestinal (GI) conditions are also performed in ambulatory surgery centers. Earlier, ASCs were only capable of performing GI-related minor surgeries; however, with increase in number of minimally invasive surgical procedures, services offered by ambulatory surgical centers have expanded and grown exponentially.

According to the U.S. Department of Health and Human Services (HHS) data records of 2014, there were 17.2 million hospital visits. These included invasive, therapeutic surgeries, and ambulatory surgeries. Around 9.94 million (57.8%) of these surgeries occurred in hospital-owned ambulatory surgery settings and the remaining 7.26 million surgeries (42.2%) were conducted in hospitals. ASCs are increasing in number and thus offer cost-effective services. In addition, favorable reimbursement coverages are being provided with regard to services provided by ASCs. The chances of contracting post-surgical, hospital-related infections are also reduced. ASCs provide specific instructions to patients regarding post-surgical homecare. Thus, with an increase in the number of ASCs and number of surgical procedures, demand for wound care is expected to increase.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wound-care-market

Further key findings from the report suggest:

In terms of revenue, the advanced dressing segment held the largest share in 2018 owing to increasing cases of chronic diseases and rising adoption of advanced wound care products across the globe
The home healthcare segment is expected to witness the fastest growth over the forecast period due to increasing geriatric population and rising adoption of negative pressure wound therapy
On the basis of application, the acute segment held the largest wound care market share in 2018 owing to rising number of surgeries and burn cases across the globe
Asia Pacific is expected to witness the fastest growth over the forecast period owing to increasing number of surgeries and rising cases of burns in this region
Prominent key players present in the wound care market include Smith and Nephew; Molnlycke Health Care AB; and Baxter International Inc.

Electronic Health Records Market Size Worth $33.41 Billion By 2025

The global electronic health records market size is expected to reach USD 33.41 billion by 2025, according to a new report by Grand View Research, Inc. The government initiatives undertaken in support of EHR adoption are most likely to accentuate the market growth.

The federal government introduced Health Information Technology for Economic and Clinical Health (HITECH) Act in 2009 for promoting usage of EHR amongst healthcare providers. The program included provision of training and assistance for health information technology (IT) workers in order to set up EHRs in the hospitals.

The National Health Services (NHS), UK is planning to convert the documentation process into digitized form completely by the year 2018. In the U.S., federal government has announced financial incentives for physicians planning to adopt EHR systems. Any average physician with at least 30% of his/her patients covered with Medicare is eligible for incentives worth USD 44,000.

Many region-specific initiatives are promoting eHealth services. For instance, EUR-Lex gave eHealth action plan for 2012 – 2020, which states the strategies for deployment of eHealth services amongst European nations.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/electronic-health-records-ehr-market

Further key findings from the report suggest:

Web-based EHR was observed to be the largest product segment owing to the fact that it can be deployed without in-house installation of complex hardware infrastructure. Moreover, web-based EHR is expected to be the fastest growing product segment in the coming years
Acute care EHR held the majority of EHR type market share at around 48% in the year 2016; whereas post-acute care EHR is likely to showcase fastest growth rate over the forecast period
The hospital use EHR segment accounted for the largest end-use share due to the excessive adoption rate among hospitals, whereas ambulatory care EHR is expected to be the fastest growing segment
As a part of the Health HITECH Act of 2009, the federal government allocated USD 27 billion for an incentive program, especially arranged for promoting adoption of EHR in hospitals and ambulatory care centers
The electronic health records market in Asia Pacific is projected to display substantial growth over the forecast period owing to various developments across major economies along with increased expenditure on healthcare IT. This regional market is expected to grow at a CAGR of 7% from 2017 to 2025
According to Healthcare Information and Management Systems Society (HIMSS) analysis adoption model for EHR, more than 2.5% of total hospitals in the Asia Pacific region crossed stage 6 of EHR implementation by the end of 2016, fueling the regional market growth
Some of the established key players in this industry include Cerner; Allscripts; McKesson Corporation; MEDITECH; Epic Systems Corporation; and NextGen Healthcare. Some of the emerging players are eClinicalWorks; Healthcare Management System; Healthland; and CureMD Healthcare; etc.

Anesthesia Monitoring Devices Market Worth $1.9 Billion By 2024

The anesthesia monitoring devices market is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications.

The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period.

Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, microprocessor-based intelligent anesthesia systems with integrated monitors enables monitoring of various parameters along with the precisely-controlled administration of the anesthetic agent.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/anesthesia-monitoring-devices-market

Further key findings from the study suggest:

Amongst the product type segments, the advanced anesthesia monitors segment held a lucrative share of over 60.0% in 2015 owing to its durability, reliability, and accuracy. Moreover, these devices monitor various significant parameters such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure.
The hospitals in the end-use segment exhibited remunerative growth in 2015; this can be attributed to the presence of advanced diagnostic and therapeutic medical technologies that enables both, faster and accurate diagnosis. Moreover, the availability of these advanced systems coupled with the presence of skilled personnel contributes towards profitable growth of this segment.
North America dominated the overall market with a revenue share of over 35.0% in 2015 owing to the presence of well-developed health care settings and the presence of a favorable reimbursement network, government funding, and increasing health awareness levels amongst the people.
However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 11.0% over the forecast period. The economic developments and the advancing healthcare system with the aid of supportive government initiatives are collectively anticipated to further assist the growth in this region.
Some key players operating in the anesthesia monitoring devices market include Masimo Corporation, Infinium Medical, Inc., Medtronic plc, GE Healthcare, Nihon Kohden Corporation, Philips Healthcare, Mindray Medical International Ltd., Drägerwerk AG & Co. KGaA, and Schiller AG. New product development, mergers, and collaborations are some key initiatives taken to sustain themselves in the competition.
For instance, Masimo Corporation incorporated Oxygen Reverse Index (ORI) which measures the oxygen levels and provides real-time information with regard to the patient’s oxygen reserve in synchronization with the partial pressure of oxygen to prevent hyperoxia conditions (oxygen levels above normal) in patients that are receiving auxiliary oxygen supply whilst undergoing surgery.

Healthcare Cyber Security Market Worth $10.85 Billion By 2022

Global healthcare cyber security market size is expected to reach nearly USD 10,848.87million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to the growth of the market include the increasing incidences of cyber attacks for misuse of electronic patient health records (E-PHR), social security records, IP theft, and others.

Cyber attacks are constantly increasing across the globe. On previous encounters it was witnessed that cyber attacks were focused on stealing, financial information, billing information, and bank account numbers using stolen devices with un-encrypted data, phishing and spam mails. Technological advancements have led to advanced cyber warfare using SQL injections, advanced persistent threats (APT), zero day attacks, and advanced malware.

Lack of adequate IT spending by healthcare organizations and lack of awareness about cyber crime have exposed the vulnerabilities of healthcare organizations. The overall impact of cyber attacks on the hospitals and healthcare systems is estimated to be nearly six billion per year.

Furthermore, these organizations face internal threats due to factors such as the use of cloud services, unsecure networks, employee negligence, bring your own device (BYOD), lack of internal identification and security systems, stolen devices with un-encrypted files.

Healthcare cyber security market is segmented by, type of threat into malware, ddos, advanced persistent threat (apt), spyware, lost and stolen devices, others. In 2013, Boston Scientific, St.Jude Medical and, Medtronic witnessed cyber attacks and hacking. In 2015, Anthem, which is the second largest health insurance provider in the U.S., witnessed a massive cyber attack leading to loss of 80 million customer records.

Security information and event management (SIEM),risk and compliance management, DDoS mitigation, antivirus, antimalware, identity and access management, intrusion detection system (IDS)/intrusion prevention system (IPS) and others are the solutions included in the scope of the study. These solutions can be used individually or can be used as a suite of products providing layer wise security.

Market dynamics in this sector are dependent on the type of threat, effectiveness, and frequency of attack, ability to detect and destroy. New types of threats are detected each day, hence, the solutions need to be upgraded constantly to provide adequate firewall security and prevent data breach.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/healthcare-cyber-security-market

Further key findings from the study suggest:

In 2014, North America held the largest market share of more than 41% owing to the presence of sophisticated healthcare infrastructure, and increasing collaboration between pharmaceutical, medical device industries, with regulatory authorities. This can be illustrated using the U.S FDA guidance document on networked medical devices.
Furthermore, the U.S. is a prime target for cyber crimes due to, the presence of large fortune 500 healthcare organizations, full scale implementation of digital patient records, and use of extensive social security ids for various transactions.
Asia Pacific is identified as one of the most lucrative regional market, growing at a CAGR of over 8.5% during the forecast period. Rapidly improving healthcare infrastructure and high level economic growth in developing countries such as China, India, and South Korea is expected to boost usage rates over the forecast period.
Increasing number of internet users in China and India is expected to create a huge user base vulnerable to cyber attacks. According to data published by the Internet and Mobile Association of India (IAMAI), the internet user base in India is expected to reach nearly 402 million by December 2015
Key players operating in the healthcare cyber security market include, Cisco, IBM, MacAfee, Paulo Alto Networks, Symantec, Trend Micro Lockheed Martin, FireEye, Northrop Grumma, Kaspersky etc.

Fluoroscopy Equipment Market Size Worth $4.74 Billion By 2025

The global fluoroscopy systems/equipment market size is expected to reach USD 4.74 billion by 2025, according to a new report by Grand View Research, Inc. The unprecedented growth is believed to be a consequence of rising patient preference for minimally invasive surgeries. These devices facilitate early diagnosis and reduce treatment duration in majority of surgical procedures.

The growing demand is also a consequence of improved cost-efficiency, safety, efficacy, rapid recovery, and reduced hospital stay. These factors anticipated to fuel the demand for fluoroscopy equipment over the forecast period. Other advantages include fewer incision wounds and postsurgical complications that lead to higher patient satisfaction.

The market is also driven by technological advancements such as incorporation of radiation dose monitoring tools for optimized radiation in fluoroscopy equipment. Other advancements include robotically controlled C-arms, integrated navigation tools, and image guidance software. These advancements have led to enhanced image guidance during interventional, ablation, and biopsy procedures as well as improved optimization of working procedures.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/fluoroscopy-market

Further Key Findings From the Report Suggest:

C-arms segment is predicted to witness exponential growth owing to high cost-efficiency and wide applicability in different fields such as traumatology, orthopedics, vascular surgery for intraoperative imaging, and others
Cardiovascular emerged as the largest application segment in 2016 as a consequence of high prevalence of cardiovascular diseases, raising the clinical urgency for adoption of fluoroscopy equipment
Hospitals held the largest share in end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment
North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide platform for growth through consistent approvals of new product
The fluoroscopy equipment market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration
GE Healthcare, Philips Healthcare, and Siemens Healthineers together accounted for a dominant share in the global fluoroscopy equipment market in 2016
The key companies are aggressively undertaking collaborative strategies, new and advanced product development activities, and mergers & acquisitions leading to significant growth
In May 2015, Philips Healthcare launched DuoDiagnost, an integrated radiography and fluoroscopy system. This equipment was launched to yield higher price-performance ratio in different applications and achieve a greater return on investment